Omeros EBITDA 2010-2025 | OMER

Omeros ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Omeros Annual EBITDA
(Millions of US $)
2024 $-167
2023 $-162
2022 $-161
2021 $-172
2020 $-155
2019 $-144
2018 $-111
2017 $-43
2016 $-54
2015 $-71
2014 $-70
2013 $-50
2012 $-37
2011 $-27
2010 $-30
2009 $-20
Omeros Quarterly EBITDA
(Millions of US $)
2025-03-31 $-34
2024-12-31 $-35
2024-09-30 $-35
2024-06-30 $-59
2024-03-31 $-39
2023-12-31 $-39
2023-09-30 $-47
2023-06-30 $-40
2023-03-31 $-36
2022-12-31 $-38
2022-09-30 $-50
2022-06-30 $-37
2022-03-31 $-35
2021-12-31 $-43
2021-09-30 $-40
2021-06-30 $-45
2021-03-31 $-45
2020-12-31 $-17
2020-09-30 $-25
2020-06-30 $-27
2020-03-31 $-23
2019-12-31 $-27
2019-09-30 $-11
2019-06-30 $-9
2019-03-31 $-19
2018-12-31 $-18
2018-09-30 $-35
2018-06-30 $-30
2018-03-31 $-27
2017-12-31 $-14
2017-09-30 $-5
2017-06-30 $-12
2017-03-31 $-13
2016-12-31 $-12
2016-09-30 $-12
2016-06-30 $-11
2016-03-31 $-19
2015-12-31 $-18
2015-09-30 $-19
2015-06-30 $-16
2015-03-31 $-18
2014-12-31 $-20
2014-09-30 $-17
2014-06-30 $-17
2014-03-31 $-16
2013-12-31 $-14
2013-09-30 $-13
2013-06-30 $-13
2013-03-31 $-10
2012-12-31 $-7
2012-09-30 $-13
2012-06-30 $-8
2012-03-31 $-8
2011-12-31 $-10
2011-09-30 $-6
2011-06-30 $-5
2011-03-31 $-6
2010-12-31 $-8
2010-09-30 $-7
2010-06-30 $-7
2010-03-31 $-6
2009-12-31 $-5
2009-09-30 $-4
2009-06-30 $-6
2009-03-31 $-5
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.198B $0.000B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.324B 38.13
Stryker (SYK) United States $149.641B 31.29
EssilorLuxottica (ESLOY) France $137.721B 0.00
Medtronic (MDT) Ireland $114.146B 16.18
Lonza Group Ag (LZAGY) Switzerland $51.237B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.534B 28.19
GE HealthCare Technologies (GEHC) United States $34.575B 16.42
Agilent Technologies (A) United States $34.457B 22.46
Terumo (TRUMY) Japan $25.051B 32.54
Koninklijke Philips (PHG) Netherlands $23.235B 16.30
Insulet (PODD) United States $20.934B 82.17
Zimmer Biomet Holdings (ZBH) United States $18.835B 12.10
Baxter (BAX) United States $15.298B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $13.441B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.887B 23.97
Lantheus Holdings (LNTH) United States $5.776B 14.57
Prestige Consumer Healthcare (PBH) United States $3.897B 17.41
Perrigo (PRGO) Ireland $3.742B 9.48
Haemonetics (HAE) United States $3.724B 16.96
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.454B 28.70
ICU Medical (ICUI) United States $3.341B 24.63
QuidelOrtho (QDEL) United States $2.135B 14.68
LeMaitre Vascular (LMAT) United States $1.910B 42.70
AtriCure (ATRC) United States $1.580B 0.00
Acuren (TIC) United States $1.397B 0.00
Phibro Animal Health (PAHC) United States $1.272B 16.26
Green Thumb Industries (GTBIF) United States $1.249B 28.09
AdaptHealth (AHCO) United States $1.247B 12.66
Neogen (NEOG) United States $1.194B 15.28
BioLife Solutions (BLFS) United States $1.068B 0.00
InMode (INMD) Israel $0.963B 9.70
Kestra Medical Technologies (KMTS) United States $0.791B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Tilray Brands (TLRY) Canada $0.679B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Owens & Minor (OMI) United States $0.667B 5.53
Evolus (EOLS) United States $0.623B 0.00
CeriBell (CBLL) United States $0.596B 0.00
Capricor Therapeutics (CAPR) United States $0.522B 0.00
Valneva SE (VALN) France $0.502B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Sanuwave Health (SNWV) United States $0.308B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.295B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Cerus (CERS) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.264B 12.01
Brainsway (BWAY) Israel $0.246B 65.00
Canopy Growth (CGC) Canada $0.232B 0.00
OraSure Technologies (OSUR) United States $0.227B 0.00
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.210B 0.00
Organigram Global (OGI) Canada $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
TriSalus Life Sciences (TLSI) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.15
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.126B 15.53
TerrAscend (TSNDF) Canada $0.104B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.082B 0.00
Veru (VERU) United States $0.081B 0.00
Jushi Holdings (JUSHF) United States $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.071B 0.00
Cytosorbents (CTSO) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Rockwell Medical (RMTI) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.29
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.82
Safety Shot (SHOT) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00